Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline.
CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel – Biotech Investments
CS MEDICA A/S / Key word(s): Regulatory Approval CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel 17-Jun-2024 / 15:35 CET/CEST
June 18, 2024